Job Stress Affecting Your Heart? Follow A Healthy Lifestyle
Peter Suciu for redOrbit.com – Your Universe Online While a stressful job can increase the risk of heart problems and lead to a 25 percent higher chance of having a heart attack or dying of other heart related illnesses, researchers have...
Latest Myocardial infarction Stories
An experimental, inexpensive iPhone application transmitted diagnostic heart images faster and more reliably than emailing photo images, according to a research study presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013. The app could help save lives by speeding treatment for the deadliest type of heart attack known as STEMI (ST segment elevation myocardial infarction), in which a clot blocks blood flow to the heart. A critical...
BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ -- -Strong Conference Presence to Include Presentations/Educational Events Featuring the MGuard(TM) Embolic Protection Stent- - Company to Host Conference Call on Thursday, May 23rd to Review MASTER Data - InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), the leader in embolic protection stents, today announced a...
- More than 18 Million Brazilians have Reimbursable Access to MGuard EPS - BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, today announced that it received reimbursement approval for the MGuard(TM) Coronary Embolic Protection Stent (EPS) from UNIMED, Brazil's largest private health care insurer. Alan Milinazzo, InspireMD's President and CEO said,...
Proof-of-Concept Clinical Study Demonstrating Predictive Power of FirstMark's Aggregate Biomarker Strategy for Predicting Near-Term Myocardial Infarction/Death, Published in JACC SAN DIEGO, May 9, 2013 /PRNewswire-iReach/ -- FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed...
Research suggests new reporting protocol for 30-day mortality for percutaneous coronary intervention to better reflect quality, performance Only 42 percent of the deaths occurring within 30 days of percutaneous coronary interventions (PCI) were attributable to complications from the procedure, according to a Cleveland Clinic study published online in the Journal of the American College of Cardiology. The research suggests alternative outcome reporting mechanisms for 30-day mortality for...
In Honor of Mother's Day, Campaign Looks to Raise $200,000 for WomenHeart and Awareness Among 42 Million Women With or at Risk of Heart Disease MORRISTOWN, N.J., May 7, 2013 /PRNewswire/ -- Bayer HealthCare, the makers of Bayer® Aspirin, WomenHeart: The National Coalition for Women with Heart Disease, and actress, singer and author Vanessa Williams today announce their partnership to launch Handbags & Hearts, a national campaign that leverages the link between women and their...
HUDSON, N.H., May 3, 2013 /PRNewswire/ -- Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, today announced the 1-year results of the INFUSE-AMI (Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. Dr. Gregg Stone, the principle investigator, presented the exciting findings at the 62(nd) Annual American College of Cardiology Conference in San Francisco, CA. INFUSE-AMI's primary endpoint was reduction in infarct size...
-- Phase II, randomized, placebo-controlled study at Glenfield Hospital, University of Leicester (UK) will measure primary efficacy endpoint of change from baseline in left ventricular ejection fraction (LVEF) post-percutaneous coronary intervention (PCI) -- TORONTO, May 2, 2013 /PRNewswire/ -- CellAegis Devices, Inc., announced today the first clinical trial program in the European Union to evaluate the use of the Company's autoRIC(TM) Device for Chronic Remote Ischemic Conditioning...
First heart pacemaker able to recruit stem cells to damaged heart tissue - THE MYOSTIM PACER - will be introduced LOS ANGELES, May 1, 2013 /PRNewswire/ -- Heart Rhythm 2013 will be held in Denver, Colorado May 8th to 11th - http://www.hrsonline.org/. Leonhardt Ventures and MyoStim Pacers are co-sponsoring @ 3pm on May 9(th) at their exhibit booth No. 657 a showcase of technologies that address heart and cardiovascular disease. Companies to be showcased include: MyoStim Pacers -...
Recent study finds that door-to-balloon times can be lowered using process improvement strategies While all heart attacks have the potential to be deadly, one type is referred to as the “widow maker” because of its high risk of death. A ST segment elevation myocardial infarction (STEMI) is a severe type of heart attack that occurs when a blockage in a coronary artery causes heart muscle to die; without prompt treatment risk of fatality increases dramatically. Coronary angioplasty, or...
Latest Myocardial infarction Reference Libraries
The cardiac stress test is a diagnostic test used in Cardiac pathology for the purpose of patient diagnosis. It measures the heart’s function while placing a heavier workload on the heart. The cardiologist cannot be at the patient’s side while at work, under stress, during a workout or pushed to the limit so this test mimics those activities in a controlled setting. How it is Performed The stress is created by increasing the workload on the cardiac system. This can be accomplished by...
